NASDAQ NMS - GLOBAL MARKET · ABEO
+2.35% · +$0.1700 · Vol 1.2M
After hours · updated 18:55:49 ET
Abeona Therapeutics Inc

Abeona Therapeutics Inc

Biotechnology
$7.41
Card
Relationship Map

Veridion Score

BETAHIGH CONF · 6/6 factorsMethodology
ABEO
Abeona Therapeutics Inc
Mon Aug 10 · session closed · Markets closed · resumes Tue 9:30 ET
STRONG

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

83/ 100
Veridion Score
STRONG · HIGH confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Mon Aug 10 · session closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ABEO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ABEO catalysts
About Abeona Therapeutics Inc
PHARMACEUTICAL PREPARATIONS
Listed since
1980
Employees
226
Country
US

Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$7.18
Day high
$7.47
Day low
$7.12
Previous close
$7.24
52W high
$7.47
-0.80% from high
52W low
$4.17
98% of range
Market cap
$412.6M
P/E
6.93×
EPS
$1.07
Beta
1.35
Shares out
57M
Volume
1.2M
0.90× rel vol
Avg volume
1.3M
VWAP
$7.30
Price history computed in-house
1W
+15.96%
1M
+6.16%
3M
+30.46%
1Y
+18.37%
YTD
+40.61%
SMA 50 $6.21 · above
SMA 200 $5.36 · above
52W position 98%

ABEO overview

Veridion Score
83
6 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ABEO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ABEO Form 4 filings
Public disclosures

Congress activity in ABEO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ABEO in the cached public ledger.

Federal contracts

ABEO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ABEO in this window.
Lobbying spend

ABEO lobbying filings, year to date.

Registered lobbying filings matched to Abeona Therapeutics Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ABEO in this window.
Loading news for ABEO
Analyst ratings
Sovereign unlock shows live analyst consensus for ABEO.
Options
Sovereign unlock shows live options positioning for ABEO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.